--- title: "SDHH released its first-quarter performance, with a net loss attributable to shareholders of 66.5246 million yuan" type: "News" locale: "en" url: "https://longbridge.com/en/news/237524321.md" description: "According to the Zhitong Finance APP, SDHH released its Q1 2025 report, stating that in the first quarter, the company achieved operating revenue of 1.024 billion yuan, a year-on-year decrease of 44.46%. The net loss attributable to shareholders of the listed company was 66.5246 million yuan. The net loss attributable to shareholders of the listed company after deducting non-recurring gains and losses was 79.2633 million yuan" datetime: "2025-04-25T08:03:09.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/237524321.md) - [en](https://longbridge.com/en/news/237524321.md) - [zh-HK](https://longbridge.com/zh-HK/news/237524321.md) generator: "portal-rs" --- # SDHH released its first-quarter performance, with a net loss attributable to shareholders of 66.5246 million yuan According to the Zhitong Finance APP, SDHH (000822.SZ) released its Q1 2025 report. In the first quarter, the company achieved an operating income of 1.024 billion yuan, a year-on-year decrease of 44.46%. The net loss attributable to shareholders of the listed company was 66.5246 million yuan. The net loss attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 79.2633 million yuan ### Related Stocks - [000822.CN](https://longbridge.com/en/quote/000822.CN.md) ## Related News & Research - [Quinto Resources Provides Corporate Updates and Announces Reinstatement of Trading and AGM](https://longbridge.com/en/news/297236929.md) - [EXPLAINER-Haiti's conflict in numbers as gangs inflict another night of terror](https://longbridge.com/en/news/297076683.md) - [The Iran War Has Turned VLCCs Into $650,000-A-Day Assets](https://longbridge.com/en/news/297374276.md) - [MSC halts Russian Black Sea service after drone attack, Bloomberg News reports](https://longbridge.com/en/news/297066548.md) - [Heidelberg Pharma, Huadong Medicine expand ADC collaboration to develop new drug candidates](https://longbridge.com/en/news/297291658.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**